Articles

Racial Differences in KRAS/BRAF Mutation Rates and Survival in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Pharmacokinetics of MEDI4736, an Anti-PD-L1 Monoclonal Antibody, in Advanced Solid Tumors

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Early Predictors of Overall Survival in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

The Current Status of Biomarkers in Use for the Treatment of Patients with mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Updated Results of the SOFT Study

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

A Mutant-Selective EGFR Inhibitor in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Ceritinib in Advanced ALK-Rearranged NSCLC: Results from the ASCEND-1 Trial

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Docetaxel and Cisplatin Plus Chemoradiation in Inoperable Stage III NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Results from RADIANT: Adjuvant Erlotinib in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Breaking News from the REVEL Study in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Page 228 of 329